Aier Eye Hospital Group logo

Aier Eye Hospital Group

Asia, Jiangsu, China, Changsha

Description

Aier Eye Hospital Group operates as a professional ophthalmic medical chain institution.

Investor Profile

Aier Eye Hospital Group has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • Hong Kong (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aier Eye Hospital Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Coyote Ventures
North America, California, United States, San Francisco
Co-Investments: 1
TPG Capital Asia
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Insight Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Highlight Capital
Asia, Jiangsu, China, Nanjin
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1

What are some of recent deals done by Aier Eye Hospital Group?

Sieran Medical

Suzhou, Jiangsu, China

Sieran Medical is a medical device company that specializes in minimally invasive surgical treatment solutions for ophthalmology.

MedicalMedical DevicePrecision Medicine
SeedSep 5, 2024
Amount Raised: $14,099,798
Zhaoke Ophthalmology Pharmaceutical

Hong Kong, Hong Kong Island, Hong Kong

Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

BiotechnologyPharmaceutical
Series BOct 12, 2020
Amount Raised: $145,000,000